Stay updated on BI 836858 & Decitabine Combo in AML Clinical Trial
Sign up to get notified when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.

Latest updates to the BI 836858 & Decitabine Combo in AML Clinical Trial page
- CheckyesterdayChange DetectedThe web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an updated version number from v2.16.0 to v2.16.1.SummaryDifference2%
- Check8 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.3%
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.9%
- Check37 days agoChange DetectedDifference0.8%
- Check44 days agoChange DetectedThe page has been updated to include new information about the trial, specifically the addition of the EudraCT number and a revision number update, while significant details about the trial's objectives and inclusion/exclusion criteria have been removed.SummaryDifference19%
- Check52 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.5%
Stay in the know with updates to BI 836858 & Decitabine Combo in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BI 836858 & Decitabine Combo in AML Clinical Trial page.